CPL-36 is a small molecule that inhibits phosphodiesterase 10A. It is being studied for its effects on dyskinesia, which are abnormal involuntary movements often associated with Parkinson's treatment. Inhibiting this enzyme could reduce these motor complications.
Discover our Products
Science-based and high-quality devices
